Award

Collaborative study of pharmacoepidemiology toward personalized medicine for non-communicable diseases

Description: In this study, we investigated whether the variation in genes involved in lipid metabolism modify the effect of the 3-hydroxymethyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors on serum low density lipoprotein cholesterol concentration reduction, using the information from treating physicians and pharmacies, laboratory assessments and genomic data in the Rotterdam Study in the Netherlands, a prospective population-based cohort study that aims to study the frequency and determinants of diseases in middle-aged and elderly individuals,.We also verified the pharmacoepidemiological data from a longitudinal cohort study in Japan.

Funder: Japan Society for the Promotion of Science

Amount: ¥2,860,000

Funding type: fellowship

Funder scheme: Grant-in-Aid for Research Activity Start-up

Start date: 2016-08-26

End date: 2018-03-31

Investigator: Azusa HASHIMOTO

Institution: Showa Pharmaceutical University

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

Funded outputs count: 0

Funder award ID: 16H07201

OpenAlex ID: G7604126282